Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Stock Watch: Robust Diagnostics And Biosimilar Erosion Vie In Roche’s Q2

COVID-19 Testing May Support Roche Longer Than Expected

Aug 02 2022

• By Andy Smith

Andy Smith — ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS

Related Content

Stock Watch: Contrasting Novartis And J&J Stock Movements Defy Explanation

Jul 26 2022

Roche Is ‘Aiming For The Sky’ With Vabysmo Commercial Launch

Jul 21 2022

Related Companies

Roche Holding AG

Novartis AG

Johnson & Johnson

Additional Topics

Sales & Earnings Commercial Companies Biosimilars Coronavirus COVID-19 Stock Watch BioPharmaceutical

More from Stock Watch

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window